Evidence map›Paper›PMID 39993138›Full record

ArticleAnalytical chemistry2025

Fab-Induced Stabilization of an Ion Channel Receptor Enables Mechanistic Characterization of Small-Molecule Therapeutics.

Soo Y Ro, Christine Jao, Angela Oh, Marc Kschonsak, Tianbo Li, Daniel Austin, Demi Maria Z Greiner, Lijuan Zhou, Yingnan Zhang, Jun Chen and 1 more

Abstract read
In one paragraph

Article in Analytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Soo Y RoDepartment of Biochemical and Cellular Pharmacology, Genentech, Inc. All located at 1 DNA Way, South San Francisco, California 94080, United States.ORCID 0000-0003-0102-4349
Christine JaoDepartment of Protein Sciences, Genentech, Inc. All located at 1 DNA Way, South San Francisco, California 94080, United States.ORCID 0009-0003-2597-8937
Angela OhDepartment of Protein Sciences, Genentech, Inc. All located at 1 DNA Way, South San Francisco, California 94080, United States.ORCID 0009-0004-0624-0619
Marc KschonsakDepartment of Protein Sciences, Genentech, Inc. All located at 1 DNA Way, South San Francisco, California 94080, United States.
Tianbo LiDepartment of Biochemical and Cellular Pharmacology, Genentech, Inc. All located at 1 DNA Way, South San Francisco, California 94080, United States.
Daniel AustinDepartment of Biochemical and Cellular Pharmacology, Genentech, Inc. All located at 1 DNA Way, South San Francisco, California 94080, United States.
Demi Maria Z GreinerDepartment of Biochemical and Cellular Pharmacology, Genentech, Inc. All located at 1 DNA Way, South San Francisco, California 94080, United States.ORCID 0009-0002-3317-5088
Lijuan ZhouDepartment of Early Discovery Biochemistry, Genentech, Inc. All located at 1 DNA Way, South San Francisco, California 94080, United States.
Yingnan ZhangDepartment of Early Discovery Biochemistry, Genentech, Inc. All located at 1 DNA Way, South San Francisco, California 94080, United States.
Jun ChenDepartment of Biochemical and Cellular Pharmacology, Genentech, Inc. All located at 1 DNA Way, South San Francisco, California 94080, United States.
John G QuinnDepartment of Biochemical and Cellular Pharmacology, Genentech, Inc. All located at 1 DNA Way, South San Francisco, California 94080, United States.ORCID 0000-0002-4664-6232

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Developing small-molecule (SM) therapeutics that target membrane proteins (MPs) is often challenging, because few biophysical methods can handle the detergents required to maintain target stability. Here, we report a surface plasmon resonance (SPR)-based methodology that enables the characterization of interactions between SMs and an ion channel receptor (MP1) in complex with a stabilizing antibody fragment (Fab) and surfactant. Briefly, a stable MP1-Fab complex was formed by coimmobilizing MP1 with an anti-MP1-Fab within the hydrogel film to study the interactions of MP1 with SMs. The critical micelle concentration (CMC) is the concentration at which 50% of the surfactant monomers are assembled into micelles. Micelles readily absorb compounds resulting in compound-loaded micelles that generate high nonspecific binding and hinder resolution of SM binding responses. This micelle-induced interference was avoided by utilizing a weak detergent at a concentration below its CMC, allowing for the resolution of compound binding to a solvent-exposed pocket. Additional Fab stabilization was required to rescue binding at a second pocket buried within the transmembrane region of MP1. The resulting SPR-based assay proved invaluable during hit-to-lead optimization by progressing structure-activity relationship (SAR) studies and resolving the mechanism of action (MoA).

Indexed as

Immunoglobulin Fab FragmentsIon ChannelsSmall Molecule LibrariesHumansMicellesSurface-Active AgentsSurface Plasmon ResonanceImmunoglobulin Fab FragmentsIon ChannelsMicellesSmall Molecule LibrariesSurface-Active Agents

Identifiers

PMID39993138
PMCPMC11913017

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.